Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden. This discovery paves the way for new treatments for hormone-resistant prostate cancer.
More...Penile Length Shortening After Radical Prostatectomy: Men's Responses
Article Date: 06 Dec 2009
UroToday.com - Erectile dysfunction is the most commonly recognized side effect of radical prostatectomy (RP) for prostate cancer (CaP). However, post-surgery penile length shortening (PLS) is known to occur in up to three-fourths of men. The impact of PLS has not previously been assessed.
More...Risk Of Male Sexual Dysfunction Increases Following Workplace BPA Exposure
Article Date: 12 Nov 2009
The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality has been given a boost with new data from the European Randomized Study of Screening for Prostate Cancer (ERSPC). This shows the true impact to be far higher than previously reported up to 31%.
More...Growing Animal Penile Erectile Tissue In Lab May Benefit Patients
Article Date: 10 Nov 2009
In an advance that could one day enable surgeons to reconstruct and restore function to damaged or diseased penile tissue in humans, researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine have used tissue engineering techniques to completely replace penile erectile tissue in animals.
More...
Note: This information has been developed and provided by an independent third-party source. World Medicine does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-company sources.
